In Absence of Absenteeism: Some Thoughts on Productivity Costs in Economic Evaluations in a Post-corona Era

Pharmacoeconomics. 2022 Jan;40(1):7-11. doi: 10.1007/s40273-021-01117-3. Epub 2021 Dec 16.

Authors

Werner Brouwer¹, Samare Huls², Ayesha Sajjad², Tim Kanters^{2

3}, Leona Hakkaart-van Roijen², Job van Exel²

Affiliations

¹ Erasmus School of Health Policy and Management, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands. brouwer@eshpm.eur.nl.
² Erasmus School of Health Policy and Management, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands.
³ Institute for Medical Technology Assessment (iMTA), Rotterdam, The Netherlands.

No abstract available

Publication types

Editorial

MeSH terms

Absenteeism*
Cost of Illness
Cost-Benefit Analysis
Efficiency*
Humans